Life-long diseases need life-long treatment: Long-term safety of ciclosporin in canine atopic dermatitis

Veterinary Record

Volumn 174, Issue SUPPL.2, 2014, Pages 3-12

  Nuttall, Tim ^a   Reece, Douglas ^b   Roberts, Elizabeth ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Novaitis Animal Health US Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ANIMAL; ANIMAL DISEASE; ATOPIC DERMATITIS; CHRONIC DISEASE; DOG; DOG DISEASE; REVIEW; SAFETY; TREATMENT OUTCOME;

ANIMALS; CHRONIC DISEASE; CYCLOSPORINE; DERMATITIS, ATOPIC; DOG DISEASES; DOGS; IMMUNOSUPPRESSIVE AGENTS; SAFETY; TREATMENT OUTCOME;

EID: 84897142030     PISSN: 00424900     EISSN: None     Source Type: Journal    
DOI: 10.1136/vr.102471     Document Type: Review

References (88)

1. ALKHARFY, K. M. (2009) Influence of overt diabetes mellitus on cyclosporine pharmacokinetics in a canine model. Experimental Diabetes Research dx.doi.org/10.1155/2009/363787
2. AMATORI, F. M., GIUSIANI, V. M. M., SOLDANI, G., CORAZZA, M. & GIORGI, M. (2004) Effect of grapefruit juice on the pharmacokinetics of cyclosporine in dogs. Veterinary Record 154, 180-181
3. ARCHER, T. M., FELLMAN, C. L., STOKES, J. V., PINCHUK, L. M., LUNSFORD, K. V., PRUETT, S. B., LANGSTON, V. C. & MACKIN, A. J. (2011) Pharmacodynamic monitoring of canine T-cell cytokine responses to oral cyclosporine. Journal of Veterinary Internal Medicine 25, 1391-1397
4. BASADONNA, G., MONTORSI, F., KAKIZAKI, K. & MERRELL, R. C. (1988) Cyclosporin-A and islet function. American Journal of Surgery 156, 191-193
5. BECHSTEIN, W. O. (2000) Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transplant International 13, 313-326
6. BECO, L., GUAGUÈRE, E., LORENTEMENDEZ, C., NOLI, C., NUTTALL, T. & VROOM, M. (2013) Suggested guidelines for using systemic antimicrobials in bacterial skin infections (2): antimicrobial choice, treatment regimens and compliance. Veterinary Record 172, 156-160
7. BENSIGNOR, E. & GUAGUÈRE, E. (2004) Utilisation de la ciclosporine pour le traitement des formes rebelles de dermatite atopique canine. Pratique Medicale et Chirurgicale de L'Animal de Compagnie 39, 15-19
8. BERNSTEEN, L., GREGORY, C. R., ARONSON, L. R., LIRTZMAN, R. A. & BRUMMER, D. G. (1999) Acute toxoplasmosis following renal transplantation in three cats and a dog. Journal of the American Veterinary Medical Association 215, 1123-1126
9. BEXLEY, J., NUTTALL, T., HAMMERBERG, J., FITZGERALD, J. & HALLIWELL, R. (2013) Serum anti-Staphylococcus pseudintermedius IgE and IgG antibodies in dogs with atopic dermatitis. Veterinary Dermatology 24, 19-24
10. BLACKWOOD, L., GERMAN, A. J., STELL, A. J. & O'NEILL, T. (2004) Multicentric lymphoma in a dog after cyclosporine therapy. Journal of Small Animal Practice 45, 259-262
11. BURTON, G., BURROWS, A., WALKER, R., ROBSON, D., BASSETT, R., BRYDEN, S. & HILL, A. (2004) Efficacy of cyclosporin in the treatment of atopic dermatitis in dogs-combined results from two veterinary dermatology referral centres. Australian Veterinary Journal 82, 681-685
12. CALLAN, M. B., PREZIOSI, D. & MAULDIN, E. (2005) Multiple papillomavirus-associated epidermal hamartomas and squamous cell carcinomas in situ in a dog following chronic treatment with prednisone and cyclosporine. Veterinary Dermatology 16, 338-345
13. CAMPANA, C., REGAZZI, M., BUGGIA, I. & MOLINARO, M. (1996) Clinically significant drug interactions with cyclosporin-an update. Clinical Pharmacokinetics 30, 141-179
14. CARLOTTI, D. N., BOULET, M., DUCRET, J., MACHICOTE, G., JASMIN, P., REME, C. A. & ALBOUY, M. (2009) The use of recombinant omega interferon therapy in canine atopic dermatitis: a double-blind controlled study. Veterinary Dermatology 20, 405-411
15. CARRIER, M., TRONC, F., STEWART, D. & PELLETIER, L. C. (1991) Dose-dependent effect of cyclosporine on renal arterial resistance in dogs. American Journal of Physiology 261, H1791-H1796
16. CATHER, J. C., ABRAMOVITS, W. & MENTER, A. (2001) Cyclosporine and tacrolimus in dermatology. Dermatologic Clinics 19, 119-131
17. CIRESI, D. L., LLOYD, M. A., SANDBERG, S. M., HEUBLEIN, D. M. & EDWARDS, B. S. (1992) The sodium retaining effects of cyclosporine. Kidney International 41, 1599-1605
18. COCKBURN, I. K. P. (1989) The risks of neoplasms in patients treated with Cyclosporine A. Journal of Autoimmunity 2, 723-731
19. DAHLINGER, J., GREGORY, C. & BEA, J. (1998) Effect of ketoconazole on cyclosporine dose in healthy dogs. Veterinary Surgery 27, 64-68
20. DAIGLE, J. C., HOSGOOD, G., FOIL, C. S. & HUNTER, R. P. (2001) Effect of cimetidine on pharmacokinetics of orally administered cyclosporine in healthy dogs. American Journal of Veterinary Research 62, 1046-1050
21. DIP, R., CARMICHAEL, J., LETELLIER, I., STREHLAU, G., ROBERTS, E., BENSIGNOR, E. & ROSENKRANTZ, W. (2013) Concurrent short-term use of prednisolone with cyclosporine A accelerates pruritus reduction and improvement in clinical scoring in dogs with atopic dermatitis. BMC Veterinary Research doi: 10.1186/1746-6148-9-173
22. DOBSON, J. M., SAMUEL, S., MILSTEIN, H., ROGERS, K. & WOOD, J. L. N. (2002) Canine neoplasia in the UK: estimates of incidence rates from a population of insured dogs. Journal of Small Animal Practice 43, 240-246
23. DONATSCH, P. & RYFFEL, B. (1986) Pharmacokinetics of cyclosporine in toxicological studies. Transplantation Proceedings 18, 71-76
24. DRESSER, G. K., SPENCE, J. D. & BAILEY, D. G. (2000) Pharmacokineticpharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clinical Pharmacokinetics 38, 41-57
25. EPSTEIN, S. (1996) Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton. Journal of Bone and Mineral Research 11, 1-7
26. FAERBER, L., BRAEUTIGAM, M., WEIDINGER, G., MROWIETZ, U., CHRISTOPHERS, E., SCHULZE, H. J., MAHRLE, G., MEFFERT, H. & DRECHSLER, S. (2001) Cyclosporine in severe psoriasis. Results of a meta-analysis in 579 patients. American Journal of Clinical Dermatology 2, 41-47
27. FAVROT, C., OLIVRY, T., WERNER, A. H., NESPECCA, G., UTIGER, A., GREST, P. & ACKERMANN, M. (2005) Evaluation of papillomaviruses associated with cyclosporine induced hyperplastic verrucous lesions in dogs. American Journal of Veterinary Research 66, 1764-1769
28. FAVROT, C., STEFFAN, J., SEEWALD, W. & PICCO, F. (2010) A prospective study on the clinical features of chronic canine atopic dermatitis and its diagnosis. Veterinary Dermatology 21, 23-30
29. FELLMAN, C. L., STOKES, J. V., ARCHER, T. M., PINCHUK, L. M., LUNSFORD, K. V. & MACKIN, A. J. (2011) Cyclosporine A affects the in vitro expression of T cell activation-related molecules and cytokines in dogs. Veterinary Immunology and Immunopathology 140, 175-180
30. FONTAINE, J. & OLIVRY, T. (2001) Treatment of canine atopic dermatitis with cyclosporine: a pilot clinical study. Veterinary Record 148, 662-663
31. FUKUNAGA, K. & ORITO, K. (2012) Time-course effects of St John's wort on the pharmacokinetics of cyclosporine in dogs. Journal of Veterinary Pharmacology and Therapeutics 35, 446-451
32. GAFTER-GVILI, A., SREDNI, B., GAL, R., GAFTER, U. & KALECHMAN, Y. (2003) Cyclosporin A-induced hair growth in mice is associated with inhibition of calcineurindependent activation of NFAT in follicular keratinocytes. American Journal of Physiology-Cell Physiology 284, C1593-C1603
33. GRAY, L. L., HILLIER, A., COLE, L. K. & RAJALA-SCHULTZ, P. J. (2013) The effect of ketoconazole on whole blood and skin ciclosporin concentrations in dogs. Veterinary Dermatology 24, 118-125
34. GRIFFITHS, L. G., SULLIVAN, M. & BORLAND, W. W. (1999) Cyclosporine as the sole treatment for anal furunculosis: preliminary results. Journal of Small Animal Practice 40, 569-572
35. GUAGUÈRE, E., STEFFAN, J. & OLIVRY, T. (2004) Cyclosporin A: a new drug in the field of canine dermatology. Veterinary Dermatology 15, 61-74
36. HENDRICKS, A., ELSON-RIGGINS, J. G., RIDDLE, A. L., HOUSE, A. K., VARJONEN, K. & BOND, R. (2012) Ciclosporin modulates the responses of canine progenitor epidermal keratinocytes (CPEK) to toll-like receptor agonists. Veterinary Immunology and Immunopathology 147, 91-96
37. IWASAKI, T., NAGATA, M. & MASUDA, K. (2002) The clinical trial of cyclosporin in the treatment of canine atopic dermatitis: a non-blinded randomized antihistaminecontrolled trial. Proceedings of the 23rd Annual Meeting of the Japanese Society of Clinical Veterinary Medicine. Osaka. pp 90-94
38. KATAYAMA, M., IGARASHI, H., TANI, K., NEZU, Y., HARADA, Y., YOGO, T., HARA, Y., AOKI, S. & TAGAWA, M. (2008) Effect of multiple oral dosing of fluconazole on the pharmacokinetics of cyclosporine in healthy beagles. Journal of Veterinary Medical Science 70, 85-88
39. KEARSLEY-FLEET, L., O'NEILL, D. G., VOLK, H. A., CHURCH, D. B. & BRODBELT, D. C. (2013) Prevalence and risk factors for canine epilepsy of unknown origin in the UK. Veterinary Record doi: 10.1136/vr.101133
40. KOVALIK, M., MELLANBY, R. J., EVANS, H., BERRY, J., VAN DEN BROEK, A. H. M. & THODAY, K. L. (2012) Ciclosporin therapy is associated with minimal changes in calcium metabolism in dogs with atopic dermatitis. Veterinary Dermatology 23, 481-486
41. KOVALIK, M., TASZKUN, I., POMORSKI, Z., KOZAK, M., POMORSKA, D., SZCZEPANIK, M., WILKOLEK, P., PALENIK, L., SHAW, D. J., VAN DEN BROEK, A. H. M. & THODAY, K. L. (2011a) Evaluation of a human generic formulation of ciclosporin in the treatment of canine atopic dermatitis with in vitro assessment of the functional capacity of phagocytic cells. Veterinary Record doi: 10.1136/vr.c7365
42. KOVALIK, M., THODAY, K. L., HANDEL, I. G., DE C. BRONSVOORT, B. M., EVANS, H., VAN DEN BROEK, A. H. M. & MELLANBY, R. J. (2011b) Ciclosporin A therapy is associated with disturbances in glucose metabolism in dogs with atopic dermatitis. Veterinary Dermatology 22, 173-180
43. LEBWOHL, M., ELLIS, C., GOTTLIEB, A., KOO, J., KRUEGER, G., LINDEN, K., SHUPACK, J. & WEINSTEIN, G. (1998) Cyclosporine consensus conference: with emphasis on the treatment of psoriasis. Journal of the American Academy of Dermatology 39, 464-475
44. MARKHAM, T., WATSON, A. & ROGERS, S. (2002) Adverse effects with long-term cyclosporin for severe psoriasis. Clinical and Experimental Dermatology 27, 111-114
45. MOUATT, J. G. (2002) Cyclosporin and ketoconazole interaction for treatment of perianal fistulas in the dog. Australian Veterinary Journal 80, 207-211
46. NAM, H-S., MCANULTY, J. F., KWAK, H-H., YOON, B-I., HYUN, C., KIM, W-H. & WOO, H-M. (2008) Gingival overgrowth in dogs associated with clinically relevant cyclosporine blood levels: observations in a canine renal transplantation model. Veterinary Surgery 37, 247-253
47. NAVARRO, L., VERDE, M. T., ORTUNEZ A. & BASURCO, A. (2008) Leishmania reactivation in an atopic dog treated with cyclosporine A. Veterinary Dermatology 19 (suppl 1), 65-66
48. NERURKAR, M. M., BURTON, P. S. & BORCHARDT, R. T. (1996) The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system. Pharmaceutical Research 13, 528-534
49. NUTTALL, T. J. & HALLIWELL, R. E. W. (2001) Serum antibodies to Malassezia yeasts in canine atopic dermatitis. Veterinary Dermatology 12, 327-332
50. Nuttall, T. J., McEwa n, N. A., Bensignor, E., Cornegliani, L., Lowenstein, C. & Rème, C. A. (2012) Comparable efficacy of a topical 0.0584% hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis. Veterinary Dermatology 23, 4-10
51. O'NEILL, T., EDWARDS, G. A. & HOLLOWAY, S. (2004) Efficacy of combined cyclosporine A and ketoconazole treatment of anal furunculosis. Journal of Small Animal Practice 45, 238-243
52. OLIVRY, T. & BIZIKOVA, P. (2013) A systematic review of randomized controlled trials for prevention or treatment of atopic dermatitis in dogs: 2008-2011 update. Veterinary Dermatology 24, 97-117
53. OLIVRY, T., DEBOER, D. J., FAVROT, C., JACKSON, H. A., MUELLER, R. S., NUTTALL, T. & PRELAUD, P. (2010b) Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis. Veterinary Dermatology 21, 233-248
54. OLIVRY, T., FOSTER, A. P., MUELLER, R. S., MCEWAN, N. A., CHESNEY, C. & WILLIAMS, H. C. (2010a) Interventions for atopic dermatitis in dogs: a systematic review of randomized controlled trials. Veterinary Dermatology 21, 4-22
55. OLIVRY, T. & MUELLER, R. S. (2003) Evidence based veterinary dermatology: a systemic review of the pharmacotherapy of atopic dermatitis. Veterinary Dermatology 14, 121-146
56. OLIVRY, T., RIVIERRE, C., JACKSON, H. A., MURPHY, K. M., DAVIDSON, G. & SOUSA, C. A. (2002b) Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial. Veterinary Dermatology 13, 77-87
57. OLIVRY, T., RIVIERRE, C. & MURPHY K. M. (2003) Maintenance treatment of canine atopic dermatitis with cyclosporine: decreasing dosages or increasing intervals? Veterinary Dermatology 14, 220 (abstract).
58. OLIVRY, T., STEFFAN, J., FISCH, R. D., PRELAUD, P., GUAGUÈRE, E., FONTAINE, J. & CARLOTTI, D. N. (2002a) Randomized controlled trial of the efficacy of cyclosporine in the treatment of atopic dermatitis in dogs. Journal of the American Veterinary Medical Association 221, 370-377
59. PALMEIRO, B. S. (2013) Cyclosporine in veterinary dermatology. Veterinary Clinics of North America: Small Animal Practice 43, 153-171
60. PAUL, A. E. H., MANSFIELD, C. S. & THOMPSON, M. (2010) Presumptive Nocardia spp infection in a dog treated with cyclosporin and ketoconazole. New Zealand Veterinary Journal 58, 265-268
61. PETERSON, A. L., TORRES, S. M. F., RENDAHL, A. & KOCH, S. N. (2012) Frequency of urinary tract infection in dogs with inflammatory skin disorders treated with ciclosporin alone or in combination with glucocorticoid therapy: a retrospective study. Veterinary Dermatology 23, 201-205
62. PUGLIESE, A., GUIDICE, E., NIUTTA, P. P., BRITTI, D. & CATARSINI, O. (1997) Cyclosporine plus pentavalent antimony in the treatment of canine leishmaniasis. Journal of Veterinary Pharmacology and Therapeutics 20, 156-157
63. RADOWICZ, S. N. & POWER, H. T. (2005) Long-term use of cyclosporine in the treatment of canine atopic dermatitis. Veterinary Dermatology 16, 81-86
64. RADWANSKI, N. E., CERUNDOLO, R., SHOFER, F. S., HANLEY, M. J. & COURT, M. H. (2011) Effects of powdered whole grapefruit and metoclopramide on the pharmacokinetics of cyclosporine in dogs. American Journal of Veterinary Research 72, 687-693
65. RAMALHO, V. L. C., RAMALHO, H. J., CIPULLO, J. P., AZOUBEL, R. & BURDMANN, E. A. (2007) Comparison of azithromycin and oral hygiene program in the treatment of cyclosporine-induced gingival hyperplasia. Renal Failure 29, 265-270
66. ROBERTS, E. S., GIRALDO, C., HAUTEKEETE, L., ROLANDO, B. & REECE, D. (2012a) Atopica® pharmacovigilance: a review of the canine data. Novartis Animal Health Dermatology Symposium, World Congress of Veterinary Dermatology. Vancouver. pp 22-23
67. ROBERTS, E. S., KING, S., ROYCROFT, L., DEMIN, I., MCDEVITT, H., FINK, M., SILBER, H., RENARD, D., PEYROU, M., SEEWALD, W., AND STEFFAN, J. (2012b). Cyclosporine in felines: is blood monitoring of value? Novartis Animal Health Dermatology Symposium, World Congress of Veterinary Dermatology. Vancouver. pp 16-17
68. ROBSON, D. (2003) Review of the pharmacokinetics, interactions and adverse reactions of cyclosporine in people, dogs and cats. Veterinary Record 152, 739-748
69. ROBSON, D. C. & BURTON, G. G. (2003) Cyclosporin: applications in small animal dermatology. Veterinary Dermatology 14, 1-9
70. ROSENBERG, A., ROSENKRANTZ, W., GRIFFIN, C., ANGUS, J. & KEYS, D. (2013) Evaluation of azithromycin in systemic and toothpaste forms for the treatment of ciclosporin-associated gingival overgrowth in dogs. Veterinary Dermatology 24, 337-343
71. SANTORO, D., MARSELLA, R. & HERNANDEZ, J. (2007) Investigation on the association between atopic dermatitis and the development of mycosis fungoides in dogs: a retrospective case-control study. Veterinary Dermatology 18, 101-106
72. SCHMIEDT, C. W., GRIMES, J. A., HOLZMAN, G. & MCANULTY, J. F. (2009) Incidence and risk factors for development of malignant neoplasia after feline renal transplantation and cyclosporine-based immunosuppression. Veterinary and Comparative Oncology 7, 45-53
73. SEIBEL, W., SUNDBERG, J. P., LESKO, L. J., SAUK, J. J., MCCLEARY, L. B. & HASSELL, T. M. (1989a) Cutaneous papillomatous hyperplasia in Cyclosporine A treated beagles. Journal of Investigative Dermatology 93, 224-230
74. SEIBEL, W., YAHIA, N. A., MCCLEARY, L. B., LESKO, L. J. & HASSELL, T. M. (1989b) Cyclosporine-induced gingival overgrowth in beagle dogs. Journal of Oral Pathology and Medicine 18, 240-245
75. STABELLINI, G., CARINCI, F., BEDANI, P. L., CALASTRINI, C., DEMATTEI, M., SCAPOLI, L., CARUSO, A., CALVITTI, M. & LOCCI, P. (2002) Cyclosporin A and transforming growth factor beta modify the pattern of extracellular glycosaminoglycans without causing cytoskeletal changes in human gingival fibroblasts. Transplantation 73, 1676-1679
76. STEFFAN, J., ALEXANDER, D., BROVEDANI, F. & FISCH, R. D. (2003) Comparison of cyclosporine A with methylprednisolone for treatment of canine atopic dermatitis: a parallel, blinded, randomized controlled trial. Veterinary Dermatology 14, 11-22
77. STEFFAN, J., FAVROT, C. & MUELLER, R. (2006) A systematic review and metaanalysis of the efficacy and safety of cyclosporin for the treatment of atopic dermatitis in dogs. Veterinary Dermatology 17, 3-16
78. STEFFAN, J., PARKS, C. & SEEWALD, W. (2005) Clinical trial evaluating the efficacy and safety of cyclosporine in dogs with atopic dermatitis. Journal of the American Veterinary Medical Association 226, 1855-1863
79. STEFFAN, J., STREHLAU, G., MAURER, M. & ROHLFS, A. (2004) Cyclosporin A pharmacokinetics and efficacy in the treatment of canine atopic dermatitis. Journal of Veterinary Pharmacology and Therapeutics 27, 231-238
80. THELEN, A., MUELLER, R. S., LINEK, M., PETERS, S., STECHMANN, K. & STEFFAN, J. (2006) Influence of food intake on the clinical response to cyclosporin A in canine atopic dermatitis. Veterinary Record 159, 854-856
81. THOMASON, J., LUNSFORD, K., STOKES, J., PINCHUK, L., WILLS, R., LANGSTON, C., PRUETT, S. & MACKIN, A. (2012) The effects of cyclosporine on platelet function and cyclooxygenase expression in normal dogs. Journal of Veterinary Internal Medicine 26, 1389-1401
82. VADEN, S. L. (1997) Cyclosporine. Seminars in Veterinary Medicine and Surgery-Small Animal 12, 161-166
83. VADEN, S. L., BREITSCHWERDT, E. B., ARMSTRONG, P. J., CORREA, M. T., BROWN, C., POLZIN, D. J. & OTHERS (1995) The effects of cyclosporine versus standard care in dogs with naturally occurring glomerulonephritis. Journal of Veterinary Internal Medicine 9, 259-266
84. VAN DEN BORNE, B., LANDEWE, R. B. M., HOUKES, I., SCHILD, F., VAN DER HEYDEN, P. C. W., HAZES, J. M. W. & OTHERS (1998) No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis. Arthritis and Rheumatism 41, 1930-1937
85. WAHLSTROM, H. E., LAVELLEJONES, M., ENDRES, D., AKIMOTO, R., KOLTERMAN, O. & MOOSSA, A. R. (1990) Inhibition of insulin release by cyclosporine and production of peripheral insulin resistance in the dog. Transplantation 49, 600-604
86. WEISCHER, M., ROCKEN, M. & BERNEBURG, M. (2007) Calcineurin inhibitors and rapamycin: cancer protection or promotion? Experimental Dermatology 16, 385-393
87. WERNER, A. H. (2003) Psoriasiform-lichenoid-like dermatosis in 3 dogs treated with microemulsified cyclosporine A. Journal of the American Veterinary Medical Association 223, 1013-1016
88. WILSON, L. S., ROSENKRANTZ, W. S. & ROYCROFT, L. M. (2011) Zinc-carnosine and vitamin E supplementation does not ameliorate gastrointestinal side effects associated with ciclosporin therapy of canine atopic dermatitis. Veterinary Dermatology 22, 53-60